TY - JOUR
T1 - Determination of manidipine in human plasma by UPLC-MS/MS and its application to a bioequivalence study
AU - Huong, Nguyen Lan
AU - Hoang, Nguyen Huu
AU - Hong, Sung Yong
AU - Park, Je Won
N1 - Funding Information:
This work was supported by the National Research Foundation of Korea (NRF) grant (2012R1A1A2039424, 2015R1A2A2A01002524), and by the grant (PJ011066) funded by the Next-Generation BioGreen21 program, Rural Development Administration.
Publisher Copyright:
© 2016 Bentham Science Publishers.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2016/5/1
Y1 - 2016/5/1
N2 - A rapid and highly sensitive method for the quantification of manidipine in human plasma was developed. Cleanup utilizing a 96-well solid-phase extraction technique is a simple and high–throughput method for extracting both manidipine and its internal standard felodipine from the quality-control samples: 97.5±2.1% for manidipine and 95.6±2.5% for IS. The ultra-performance liquid chromatography (UPLC) with tandem mass spectrometry (MS/MS) analytical tool, operated in a selective reaction monitoring mode was validated for manidipine quantification. The limit of detection and the lower limit of quantification were found to be 0.03 and 0.07 ng/mL, respectively. The intra- and inter-day precision was <3%, and accuracies ranged from 93.6 to 98.3%. A combination of the high-throughput SPE cleanup, and the sensitive and robust UPLC–MS/MS detection of manidipine at the picogram level was successfully applied to a bioequivalence study; Tmax, Cmax, and AUC0-12 obtained from reference tablet were averaged at 2.26 h, 5.78 ng/mL, and 20.82 ng h/mL, whereas those from test one were at 2.31 h, 5.64 ng/mL, and 21.37 ng h/mL, respectively.
AB - A rapid and highly sensitive method for the quantification of manidipine in human plasma was developed. Cleanup utilizing a 96-well solid-phase extraction technique is a simple and high–throughput method for extracting both manidipine and its internal standard felodipine from the quality-control samples: 97.5±2.1% for manidipine and 95.6±2.5% for IS. The ultra-performance liquid chromatography (UPLC) with tandem mass spectrometry (MS/MS) analytical tool, operated in a selective reaction monitoring mode was validated for manidipine quantification. The limit of detection and the lower limit of quantification were found to be 0.03 and 0.07 ng/mL, respectively. The intra- and inter-day precision was <3%, and accuracies ranged from 93.6 to 98.3%. A combination of the high-throughput SPE cleanup, and the sensitive and robust UPLC–MS/MS detection of manidipine at the picogram level was successfully applied to a bioequivalence study; Tmax, Cmax, and AUC0-12 obtained from reference tablet were averaged at 2.26 h, 5.78 ng/mL, and 20.82 ng h/mL, whereas those from test one were at 2.31 h, 5.64 ng/mL, and 21.37 ng h/mL, respectively.
KW - 96-well solid-phase extraction plate
KW - Bioequivalence study
KW - Liquid chromatography
KW - Manidipine
KW - Mass spectrometry
UR - http://www.scopus.com/inward/record.url?scp=84961575919&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84961575919&partnerID=8YFLogxK
U2 - 10.2174/1573412911999151012151244
DO - 10.2174/1573412911999151012151244
M3 - Article
AN - SCOPUS:84961575919
VL - 12
SP - 152
EP - 156
JO - Current Pharmaceutical Analysis
JF - Current Pharmaceutical Analysis
SN - 1573-4129
IS - 2
ER -